Introduction
============

*Helicobacter pylori* (Hp) infection is a well-known step in gastric cancer susceptibility and other chronic gastric diseases in adults and children ([@B1]-[@B3]). Prevalence of Hp infection varies by geographical regions, genetic background, and socioeconomic status ([@B4]-[@B6]). Reliable and accurate detection of this infection is of importance ([@B7]). Hp can be detected either invasively or non-invasively. Invasive methods, such as histopathology-based, culture, or rapid urease test (RUT), need gastric mucosa specimens obtained through endoscopy. Although invasive methods are commonly used as gold standards, studies demand less invasive or noninvasive methods such as urea breath test (UBT) and Hp stool antigen (HpSA) test ([@B8]-[@B10]).

There is not a definite method as a gold standard to detect Hp infection ([@B8], [@B11], [@B12]). Diagnostic and predictive values and the cost-effectiveness of tests help to choose the optimal approach ([@B13], [@B14]). Both the UBT and HpSA tests can detect an active Hp infection, and their sensitivity is affected by the recent medications, which limits the use of noninvasive tests for a larger population ([@B14]). UBT is sensitive, specific, and accurate; however, it is expensive and needs trained operators. HpSA test is widely used as a simple, inexpensive, and feasible noninvasive method to diagnose and follow-up Hp infection, as an alternative method to invasive and other noninvasive approaches such as UBT ([@B15], [@B16]).

Iran, as a developing country, is experiencing high burdens of Hp-associated non-communicable diseases ([@B17], [@B18]). The current study aimed at evaluating the diagnostic and predictive values of HpSA test for Hp infection in Iranian patients with dyspepsia.

Materials and Methods
=====================

**Subjects**

The current cross sectional study was performed on 100 patients with dyspepsia within the age range of 20 to 70 years referred to Imam Reza Specialized Polyclinic affiliated to Arak University of Medical Sciences, Arak, Iran, from March to October 2015. All participants signed the informed consent prior to enrollment. The data pertaining demographics, medications, and medical history of patients were recorded using a questionnaire. Exclusion criteria were age under 20 years, pregnancy, post-Hp eradication, or recent use of antibiotics (within the last 2 months) or antacid medications such as proton pump inhibitors (within the last 2 weeks), and contraindications for endoscopy and biopsy such as coagulopathies. Histopathological diagnosis of Hp was considered as a gold standard.

**Endoscopy and histopathology**

Patients, sedated by a trained nurse using midazolam, underwent upper gastrointestinal endoscopy; and 2 gastric mucosal biopsies were taken from antrum and corpus according to the standard protocols. Specimens were processed and stained, using hematoxylin-eosin and Giemsa, and examined by an expert pathologist. The pathologist reported Hp colonization on an ordinal scale ranging from 0 (no colonization) to 3 (severe colonization).

**Stool samples and antigen detection**

Fresh stool samples provided in the sterile containers were immediately sent to the polyclinic laboratory. Exclusion criteria of the stool samples were diarrhea, inadequate amount and delayed delivery after collection. Examination of the stool samples to detect Hp antigen was performed using *H. pylori*Ag stool enzyme-linked immunosorbent assay (ELISA) kits (ACON, San Diego, USA). The manufacturer of the kit suggested the index values above 1.1 as positive.

**Statistical analysis**

Receiver operating characteristic (ROC) curve was drawn and the Youden J statistic was used to determine the optimal cutoff point. Area under curve (AUC) was analyzed. Sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), and diagnostic ratios were calculated for 4 cutoff points. Correlation between the age and HpSA results was evaluated using the Pearson correlation. The results of HpSA test were compared among the categories using the nonparametric Kruskal-Wallis test. P-value \<0.05 was regarded as significant. Data were analyzed using IBM SPSS Statistics v. 22.

**Ethical considerations**

The study was approved by the Ethics Committee of Arak University of Medical Sciences and all patients signed the informed consent before enrollment. Researchers were committed to the principles of the Declaration of Helsinki and had no conflict of interest.

Results
=======

The patients within the age range of 20 to 75 years (mean age= 47.51) were enrolled in the study. Forty-nine patients (49%) were male. The mean HpSA test result (index value) was 1.82 (standard deviation (SD) =2.02). Stool antigen titer was significantly correlated with age (r=0.213 \[95%CI: 0.012-0.394\], P-value=0.034). There was no significant difference in HpSA results between the 2 genders (P-value=0.284). Hp stool antigen titer was associated with severity of epithelial changes, particularly in males ([Table 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}).

###### 

Helicobacter pylori *Stool Antigen Test Results Based on Gender and Epithelial Changes*

  ----------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                                              Stool Antigen (Index Value)\   P-value[\*](#TFN2){ref-type="table-fn"}                    
                                                         \[Mean ±SD\]                                                                              
  ------------------------------------------------------ ------------------------------ ----------------------------------------- ---------------- ---------
  Gender                                                 Male                           49                                        1.59 **±**1.95   0.284

  Female                                                 51                             2.03 **±**2.08                                             

  Chronic gastritis[†](#TFN1){ref-type="table-fn"}       No                             3                                         0.17 ±0.09       \<0.001

  Mild                                                   32                             0.36 ±0.90                                                 

  Moderate                                               30                             2.35 ±2.05                                                 

  Severe                                                 35                             2.83 ±1.99                                                 

  Intestinal metaplasia[†](#TFN1){ref-type="table-fn"}   No                             89                                        1.66 **±**1.95   0.161

  Focal mild                                             6                              2.90 ±2.22                                                 

  Focal moderate                                         2                              4.87 ±0.18                                                 

  Extensive                                              3                              2.35 ±2.60                                                 

  Hp colonization[†](#TFN1){ref-type="table-fn"}         No                             49                                        0.60 ±1.20       \<0.001

  Mild                                                   17                             2.60 ±2.28                                                 

  Moderate                                               17                             3.13 ±1.74                                                 

  Severe                                                 17                             3.25 ±1.87                                                 

  Total                                                  **100**                        **1.82 ±2.02**                                             
  ----------------------------------------------------------------------------------------------------------------------------------------------------------

*CI: Confidence interval; Hp:*Helicobacter pylori*; SD: standard deviation*

  *Based on the histopathological findings (gold standard)*

  *The nonparametric Kruskal-Wallis one-way ANOVA test*

###### 

Helicobacter pylori*Stool Antigen Test Results Based on Epithelial Changes in Males and Females*

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gender                                                 Epithelial Change                                      Categories                           Count        Stool Antigen (Index Value)\         P-value[\*](#TFN4){ref-type="table-fn"}
                                                                                                                                                                  \[Mean ±SD\]                         
  ------------------------------------------------------ ------------------------------------------------------ ------------------------------------ ------------ ------------------------------------ -----------------------------------------
  Male                                                   Chronic gastritis[†](#TFN3){ref-type="table-fn"}       No                                   2            0.19 ±0.11                           \<0.001

  Mild                                                   15                                                     0.16 ±0.06                                                                             

  Moderate                                               14                                                     2.04 ±2.09                                                                             

  Severe                                                 18                                                     2.60 ±2.02                                                                             

  Intestinal metaplasia[†](#TFN3){ref-type="table-fn"}   No                                                     41                                   1.19 ±1.64   0.043                                

  Focal mild                                             5                                                      2.87 ±2.49                                                                             

  Focal moderate                                         2                                                      4.87 ±0.18                                                                             

  Extensive                                              1                                                      \- [a](#TFN5){ref-type="table-fn"}                                                     

  Hp colonization[†](#TFN3){ref-type="table-fn"}         No                                                     24                                   0.44 ±1.05   \<0.001                              

  Mild                                                   8                                                      2.45 ±2.46                                                                             

  Moderate                                               11                                                     2.73 ±1.85                                                                             

  Severe                                                 6                                                      2.98 ±1.82                                                                             

                                                         Total                                                                                       49           1.59 ±1.95                           

  Female                                                 Chronic gastritis[†](#TFN3){ref-type="table-fn"}       No                                   1            \- [a](#TFN5){ref-type="table-fn"}   0.001

                                                                                                                Mild                                 17           0.54 ±1.22                           

                                                                                                                Moderate                             16           2.62 ±2.05                           

                                                                                                                Severe                               17           3.08 ±1.98                           

                                                         Intestinal metaplasia[†](#TFN3){ref-type="table-fn"}   No                                   48           2.06 ±2.12                           0.822

                                                                                                                Focal mild                           1            \- [a](#TFN5){ref-type="table-fn"}   

                                                                                                                Focal moderate                       0            \- [b](#TFN6){ref-type="table-fn"}   

  Extensive                                              2                                                      0.91 ±1.01                                                                             

  Hp colonization[†](#TFN3){ref-type="table-fn"}         No                                                     25                                   0.75 ±1.33   \<0.001                              

  Mild                                                   9                                                      2.74 ±2.20                                                                             

  Moderate                                               6                                                      3.86 ±1.36                                                                             

  Severe                                                 11                                                     3.39 ±1.97                                                                             

                                                         Total                                                                                       51           2.03 ±2.08                           
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CI: Confidence interval; Hp: Helicobacter pylori; SD: standard deviation

Based on the histopathol*ogical findings (gold standard)*

The nonparametric Kruskal-Wallis one-way ANOVA test

One sample, no means were calculated.

No samples, no means were calculated.

According to the gold standard, 51 patients had the grades of Hp colonization and 49 had no signs of Hp infection. First, the study used 1.100 (manufacturer's protocol) as a cutoff index value to detect Hp antigen in stool. Then, the ROC curve was drawn for HpSA test ([Figure 1](#F1){ref-type="fig"}).

AUC was 0.851 (95%CI: 0.772-0.931) and significant (P-value \<0.001). Using the ROC curve, the cutoff point was 0.385 (the Youden J=0.661). The study also tried 0.110 and 5.855 as the most sensitive and the most specific cutoff points, respectively. The positive and negative results for each cutoff point were cross-tabulated against the gold standard, ie, histopathology ([Table 3](#T3){ref-type="table"}).

[Table 4](#T4){ref-type="table"} shows sensitivity, specificity, predictive values, and diagnostic ratios of HpSA test for each cutoff points.

![Receiver Operating Characteristic Curve for Helicobacter pylori Stool Antigen Test](ijp-13-038-g001){#F1}

###### 

Positive and Negative Results for Four Cutoff Points Stool Antigen Index Values to Detect Helicobacter pylor

  ----------------------------------------------------------------------------------------------------------------------------------------------
                                                Test Cutoff Point (Stool Antigen Index Value)   Total                                       
  --------------------------------------------- ----------------------------------------------- ------- ---- ---- ---- ---- ---- ---- ----- ----
  Hp colonization\                              \+                                              50      1    41   10   40   11   1    50    51
  (pathology) [a](#TFN7){ref-type="table-fn"}                                                                                               

  \-                                            41                                              8       7    42   7    42   0    49   49    

  Total                                         91                                              9       48   52   47   53   1    99   100   
  ----------------------------------------------------------------------------------------------------------------------------------------------

Hp: *Helicobacter pylori*

Gold standard

###### 

Helicobacter pylori*Stool Antigen Test Diagnostic and Predictive Values for Four Cutoff Points Stool Antigen Index Values*

  Test Characteristic   Cutoff Point (Stool Antigen Index Value)                   
  --------------------- ------------------------------------------ ------- ------- ------------------------------------
  Sensitivity (%)       98.04                                      80.39   78.43   1.96
  Specificity (%)       16.33                                      85.71   85.71   100.00
  Accuracy (%)          58.00                                      83.00   82.00   50.00
  PPV (%)               54.95                                      85.42   85.11   100.00
  NPV (%)               88.89                                      80.77   79.24   49.49
  LR+                   1.17                                       5.63    5.49    \- [a](#TFN8){ref-type="table-fn"}
  LR-                   0.12                                       0.23    0.25    0.98
  DOR                   9.75                                       24.48   21.96   \- [a](#TFN8){ref-type="table-fn"}

*PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative likelihood ratio; DOR: diagnostic odds ratio*

Unable to compute (division by 0)

Discussion
==========

Consistent with the former studies ([@B16], [@B19]-[@B25]), the current study found that HpSA test was sensitive, specific, and accurate to diagnose Hp infection (sensitivity: 80.4%, specificity: 85.7%). To avoid false negative results, which would be achieved if there was a history of chronic liver diseases (eg, cirrhosis), gastrointestinal bleeding, and antacid medications, the patients undergoing proton pump inhibitor or bismuth therapy were excluded. However, a few patients with asymptomatic gastrointestinal bleeding may have been included in the study, which may drive the results into the false negative HpSA tests ([@B21]). Besides, mild Hp colonization in the gastric mucosa accompanied by low concentrations of stool antigens could cause false negative results. Other *Helicobacter* species may cause false positive results ([@B26]). The condition of stool samples should be considered, too. Unformed or watery stool samples lead to less accurate test results due to diluted antigens ([@B27]).

It is challenging to define an appropriate cutoff point and test validations are important to find the optimal cutoff index for a distinct population ([@B28], [@B29]). The current study employed the manufacturer's cutoff index value (1.1) coming with a lower sensitivity (78.4%) and diagnostic odds ratio (DOR) of 21.96, compared with using the new cutoff index (0.385) with sensitivity and DOR of 80.4% and 24.48, respectively.

The HpSA test is quick, easy, patient-friendly, and inexpensive. Based on the rising trend of Hp-associated non-communicable diseases in Iran and the cost-effectiveness of HpSA ([@B13]), the current study findings corroborated the use of HpSA test to detect and follow-up patients with Hp infection, as an alternative to the invasive procedures.

Conclusion
==========

According to the current study findings, the new cutoff point of 0.385 was useful when a highly sensitive test (eg, in screening) or a test with low false negative rates (eg, during follow-up) is employed to diagnose Hp infection in Iranian patients with dyspepsia. The use of other non-invasive methods can confirm the HpSA test results.

Recall bias and small sample size were the potential source of limitations in the current study.
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